Sutro Biopharma’s (STRO) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reiterated their market outperform rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a report issued on Monday, Benzinga reports. JMP Securities currently has a $17.00 price objective on the stock. Other research analysts have also recently issued research reports about the company. Truist Financial cut their target price on Sutro […]
20 Sep 01:52 · The Cerbat Gem